Navigate Fool.com
Will PODD beat
the market?

Insulet (NASDAQ: PODD)

Community Rating: 2 Stars: Unattractive

36.93 -0.19 (-0.51%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.94
Previous Close $37.12
Daily Range $36.24 - $37.12
52-Week Range $30.18 - $51.31
Market Cap $2.0B
P/E Ratio -50.16
Dividend (Yield) $0.00 (0.0%)
Volume 226,853
Average Daily Volume 550,059
Current FY EPS -$0.12

How do you think PODD
will perform against the market?

Top PODD Bull/Bear Pitches


BACnumber1 (1.35)
Submitted February 13, 2010

Watch Supersize Me. Once you watch the whole movie, you'll know why this stock is poised for greatness along with any other insulin provider

0 Replies Reply Report this Post

delos2 (0)
Submitted August 11, 2008

Not a market guy, but a manufacturing guy. Insulet was my account up until last year when the printed circuit board company I worked for finally gave up to offshore pressure. I knew a lot of these guy … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

DaVita's Short-Term Weakness Is a Great Way to Play Long-Term Health Trends

DaVita has underperformed the market during the past six months, but higher diabetes rates among U.S. citizens make the company a great long-term play.

PODD Makes Notable Cross Below Critical Moving Average

PODD Makes Bullish Cross Above Critical Moving Average

Notable Two Hundred Day Moving Average Cross - PODD

Will Trifexis Rumors Hurt Eli Lilly?

The popular veterinary medicine Trifexis has been getting a lot of negative press recently due to allegations that it's killing dogs. Will these rumors damage Eli Lilly, the parent company of Trifexis manufacturer Elanco?

3 Stocks to Get on Your Watchlist

A legacy printing company that's branching out, an overseas oil and refining juggernaut, and a medical-device maker that may be a bit too pumped up are this week's must-watch stocks.

Will This Company's Artificial Pancreas Disrupt the Insulin Pump Market?

Medtronic recently received an FDA approval for the first artificial pancreas in history. How will this product affect the market for insulin pumps?

These Companies Are Set to Benefit From Worrying Health Trends

These three companies are set to benefit from rising rates of obesity within the United States.

1 Reason to Expect Big Things from Insulet

Don't just ask, "How much inventory?" Ask, "What kind?"

Friday's Top Upgrades (and Downgrades)

Analysts shift stance on Iron Mountain, Insulet, and Ciena.

See More PODD News...




Healthcare Information Services

Insulet (PODD) Description

Insulet makes the leading wearable, tubeless insulin pump for diabetics. Website: http://www.myominipod.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks